top of page
Advancing Innovations in Immunoengineering, Drug and Gene Delivery, Mucosal Theraputics and Cancer Therapy
News
-
09/23/2026: Mucommune Awarded Contraceptive Research & Development Center from NIH to Advance its Novel, Antibody-Based Non-Hormonal Contraceptives into Clinical Trials
-
11/17/2025: Mucommune Awarded ARPA-H Funding to Develop Novel In Vivo CAR-T Therapy for Cancer
-
8/11/2021: Our lead contraceptive mAb candidate is published in Science Translational Medicine. UNC Chapel Hill Press release. Media coverage: The Scientist, Wired Magazine, MedScape, WRAL TechWire.
-
7/22/2021: Inhalon, our sister company, announces partnership with Celltrion and initiates Phase 1 and 2 clinical trial.
-
3/11/2021: Mucommune in consortium that initiates first-ever clinical trial for a contraceptive mAb (ClinicalTrials.gov, NCT04731818).
bottom of page